Renalytix has officially commercially launched the KidneyIntelX testing platform with its launch partner Mount Sinai. The test is now fully integrated into the Mount Sinai health system, and goes beyond mere patient testing into a holistic approach to CKD patient support with Mount Sinai’s care delivery, physician education and support and billing pathways. This is a pivotal milestone for Renalytix triggering first commercial testing revenues, and was achieved in less than two years since Renaly ....
18 Sep 2020
Milestone reached as commercial testing begins at Mount Sinai
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Milestone reached as commercial testing begins at Mount Sinai
Renalytix Plc (RENX:LON) | 33.5 0 0.0% | Mkt Cap: 33.5m
- Published:
18 Sep 2020 -
Author:
Edward Thomason -
Pages:
3
Renalytix has officially commercially launched the KidneyIntelX testing platform with its launch partner Mount Sinai. The test is now fully integrated into the Mount Sinai health system, and goes beyond mere patient testing into a holistic approach to CKD patient support with Mount Sinai’s care delivery, physician education and support and billing pathways. This is a pivotal milestone for Renalytix triggering first commercial testing revenues, and was achieved in less than two years since Renaly ....